Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 5, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 February 2026 - 13:15

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 5, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/fymskina

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters